For patients with stage III or IV Hodgkin lymphoma, nivolumab with doxorubicin, vinblastine, and dacarbazine (N+AVD) yields ...

Researchers investigated whether induction chemotherapy improves PFS and OS in patients with locally advanced cervical cancer ...

An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, ...

For a subset of patients with inoperable or metastatic HR-positive/HER2-negative breast cancer, treatment with datopotamab ...

Biodexa Provides Update on Progression Free and Overall Survival in Phase 1 Study of MTX110 in Recurrent Glioblastoma Cohort ...

In some with grade 3 brain cancer, adding PCV chemotherapy regimen to radiation showed better survival outcomes than another ...

The U.S. Food and Drug Administration has approved Itovebi (inavolisib), in combination with palbociclib (Ibrance) and ...

Patients with limited-stage SCLC were randomly assigned to receive durvalumab with or without tremelimumab or placebo as ...

Shares of Jazz Pharmaceuticals are trading only slightly higher in the last few weeks despite two unexpected wins. Explore ...

Discover key gene signatures that could help predict the efficacy of immune checkpoint blockade therapy in patients with ...

Bank of America Securities analyst Jason Gerberry has reiterated their bullish stance on JAZZ stock, giving a Buy rating today. Jason Gerberry ...